New pharmacy opens in Ross Bridge
Ross Bridge Pharmacy in Hoover has opened in a newly built retail space in the Ross Bridge community. The pharmacy will be located near the newly opened Ross Bridge Medicine. The address is 3601 Market Street, Suite 104. Ross Bridge Pharmacy is an expansion of Bessemer-based Family Medical Services, Inc. which also operates pharmacies in Bessemer, Montevallo and Jasper.  Zach Wood will be pharm acist and manager of the location. “We are so excited to be joining the Ross Bridge community. When… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

PSBJ Interview: New EvergreenHealth CEO says health care 'must continue to evolve'
Evergreen health CEO Dr. Amy Beiter says tech companies entering the sector can benefit health care. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Ben Miller Source Type: news

Triad health system expands partnership with pregnancy app developer
Greensboro's Cone Health and a prenatal app developer are expanding the partnership the two entities forged in 2017. Washington, D.C.-based Babyscripts and Cone Health hope to develop new digital models to improve access to care for at-risk populations of expectant mothers. The partnership has in the past focused on mothers with a history of diabetes or who have developed gestational diabetes, as well as detec ting and caring for pregnancy-induced hypertension, also known as preeclampsia via Babyscripts'… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: John Joyce Source Type: news

CareFirst raises minimum wage to $15, introduces new employee benefits model
CareFirst BlueCross BlueShield has raised the minimum wage for all its employees to $15 per hour, a move that comes ahead of new requirements set to roll out statewide. Maryland's minimum wage will incrementally increase to $15 over the next seven years, following a piece of legislation passed by the Maryland General Assembly this year. Gov. Larry Hogan initially vetoed the passed legislation, but state Democrats quickly voted to override his decision. The state 's minimum wage is currently set… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Morgan Eichensehr Source Type: news

UnitedHealth CEO's pay passed $18 million in 2018; Optum chief got $21 million in his first year
UnitedHealth Group Inc. CEO David Wichmann was paid $18.1 million in 2018, a slight increase from his pay the year before. Andrew Witty, who was named CEO of UnitedHealth's Optum unit in March 2018, was paid $21.2 million in 2018. The Minnetonka-based insurer disclosed Wichmann and Witty's pay in a proxy statement filed late Friday. Wichmann's pay in 2018 was 316 times greater than that of UnitedHealth's median employee, according to the filing. Wichmann's 2018 pay was a roughly 4 percent increase… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Alex Wittenberg Source Type: news

Medical marijuana expansion advances in Texas
A record 63 marijuana-related bills were filed at the Texas Capitol this session. Only one tied to medical marijuana has made much progress, but it's got wide-ranging and bipartisan support. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Kimberly Reeves Source Type: news

Fast-growing Cincinnati firm launches zany marketing campaign
Ensemble Health Partners, which specializes in the management and collection of patient service revenue for Mercy Health-Cincinnati and other hospital systems nationwide, has launched a humorous marketing campaign, “We’re trying to bring some personality into a space that’s kind of dry but very important,” said Colt Briner, 42, who recently was hired as chief marketing officer and is based at Ensemble’s regional headquarters in Warren County’s Deerfield Township. “We’re just having… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Barrett J. Brunsman Source Type: news

A look at premium products from Denver's largest cannabis companies (Photos)
From a cannabis-infused aphrodisiac to a cigar-styled blunt, see the most expensive products from Denver's largest cannabis companies. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: James Rodriguez Source Type: news

In the money April 22: More than $18M in deals for medical devices, space tech & more
The companies announcing new funding rounds and filing paperwork with the SEC included a company that is starting to gain traction for its tendon-fixing medical device and a startup that helps guide other businesses through space. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Authors: Mike Cronin Source Type: news

Bidder protests awarding of Missouri medical marijuana tracking contract
A company seeking to provide vital oversight for medical marijuana in Missouri has filed a protest over the award of that contract to a rival. The protest filed Thursday by BioTrackTHC claims the state should not have awarded Metrc LLC the contract because it didn't fully disclose its fees, The St. Louis Post-Dispatch reports. The contract at the center of the controversy will be at the center of the state's administration of medical mar ijuana, including tracking marijuana from seed to sale, license… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 22, 2019 Category: Biotechnology Source Type: news

Need to Know: How a massive ship, a behemoth plane and a glass staircase captured our attention
I'm Rob, and I'm your guide through a more casual look at the Business Journal's week that was — and what will be. If you missed Friday’s cover story, Ashley Stewart took readers inside the EB-5 investor program and how developers are using a program meant to help areas in need of an economic boost to pepper the Seattle skyline. On a lighter note, this has been a good week for photo-hea vy stories. Not only did Seattle see its first cruise ship landing of the season (the Celebrity Eclipse is… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 21, 2019 Category: Biotechnology Authors: Robert S. Johnson Source Type: news

Medical Groups
Medical groups surveyed for this list have operations in Sacramento, El Dorado, Placer and Yolo counties. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 20, 2019 Category: Biotechnology Source Type: news

Entrepreneur of the Year candidate's Orlando supplement startup sees huge growth
This firm attributes much of its success to its effort to make sure everyone in its workforce feels empowered, rewarded and happy. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Anjali Fluker Source Type: news

Former Butler Health System exec and her husband charged with fraud and embezzlement
Scott Roskovski, a former detective for the Butler County District Attorney's office, and his wife Stephanie Roskovski, a former COO of Butler Health System, are facing dozens of charges for alleged fraud and embezzlement, according to WPXI. The indictment lists 37 charges against the two, including embezzlement from a health care benefit program beginning in 2014. To read more on this story, visit WPXI. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Source Type: news

Blue Cross affiliate awarded Medicaid contracts
Blue Cross Blue Shield of Alabama affiliate My Care Alabama has been awarded contracts from the Alabama Medicaid Agency to serve Medicaid-eligible patients in the northwest, central and eastern regions of Alabama. The contracts cover 325,000 patients and goes into effect on Oct. 1. “This is an exceptional opportunity to partner with the Medicaid Agency, and we are honored to have been selected to serve Alabama’s Medicaid population,” said Tim Vines, president and CEO of Blue Cross and Blue… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Tampa health care technology service acquires Jacksonville company
HealthAxis Group, a Tampa-based health technology service, has acquired a Jacksonville firm that develops and implements data warehouse and business intelligence solutions. Terms of the acquisition of Analytics Partners were not disclosed. The merger of the companies business operations adds “robust and proven analytics to complement the HealthAxis Group's current and powerful core platform and services,” according to a statement from HealthAxis. HealthAxis Gr oup acquired Analytics Partners’… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Crystal Owens Source Type: news

Decision helps clear the way for potential Saratoga Hospital expansion
A county planning board moved forward a zoning proposal key to Saratoga Hospital's potential multimillion-dollar expansion next to its main campus. The Saratoga County Planning Board on Thursday recommended approval of an updated Saratoga Springs zoning map that would allow medical offices to be built on land adjacent to the hospital. The new zoning still needs to be reviewed by the city's planning board and then approved by the Saratoga Spri ngs City Council. City leaders have been working on updating… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Liz Young Source Type: news

Roswell Park receives $1M anonymous gift for Oneida site
Roswell Park Comprehensive Cancer Center and Oneida Healthcare received a $1 million anonymous gift in support of a cancer infusion center in Central New York. The gift brings the two organizations to $10 million raised toward a $12 million capital campaign goal for the project, which includes an infusion clinic opened in 2017 at the Madison County hospital as well as a 6,000-square-foot radiation oncology center, slated to open in June. The third phase will be an expansion of Oneida Healthcare's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Tracey Drury Source Type: news

GSK layoffs focused on PA and U.K. sites – not Triangle
While pharmaceutical giant GlaxoSmithKline is laying off employees in an ongoing restructuring of its research and development – the Triangle's 2,600 employees appear to be outside the focus of that effort. GSK has laid off employees at its two major R&D hubs – Collegeville, Pa., and Stevenage in the U.K. The move comes months after its new R&D head Hal Barron  announced a new strategy for his unit, prioritizing innovation and moving towards delivering a pipeline of medicines with a focus… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

Md. cannabis industry set to celebrate second 4/20 with parties, discounts and munchies
The Maryland cannabis industry will celebrate its second 4/20 on Saturday — or as it's described by some in the industry, "cannabis black Friday." And dispensaries throughout Greater Baltimore are preparing for what they expect will be one of their best sales days of the year. April 20, or "4/20," represents a kind of holiday for marijuana businesses nationwide. The d ate itself serves as a term commonly used in connection with cannabis use, though its origin is subject to a lot of rumor and speculation.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Morgan Eichensehr Source Type: news

Kaiser Permanente applies predictive analytics to suicide prevention
The Kaiser Center for Health Research analyzed certain data points in the medical records of 25 million Kaiser members across the country. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Opinion: Underpaid workforce signals troubling trend for behavioral health care
An underpaid workforce presents an even more troubling trend for the behavioral health care industry, and the hundreds of thousands of people served. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Patrick C. Evans Source Type: news

Versiti Blood Research Institute wins $7.4M federal contract
Versiti Blood Research Institute in Wauwatosa won a seven-year contract valued at $7.4 million from the U.S. Department of Health& Human Services to participate in a program that protects the nation ’s blood supply and improves collection and use of blood products. Versiti Blood Research Institute will collaborate with Froedtert& the Medical College of Wisconsin, Children ’s Hospital of Wisconsin and Marshfield Clinic in the National Heart, Lung and Blood Institute’s research program. The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Rich Kirchen Source Type: news

Central Ohio's second medical marijuana dispensary to open within weeks
The second Central Ohio medical marijuana dispensary could open within weeks, depending on the state's blessing. The region's remaining seven are in various stages of construction. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Carrie Ghose Source Type: news

Proteon exploring sale after 2nd drug trial failure
Cash-strapped biotech Proteon Therapeutics is considering a merger or acquisition after shelving its lead kidney disease drug due to a second late-stage clinical trial failure. Waltham-based Proteon (Nasdaq: PRTO) disclosed in a financial filing this week that it does not have enough cash to survive for the next 12 months, with just $22 million left in the bank. Four members of the company's board of directors further resigned this week. It will be laying off an undisc losed amount of its 17 employees… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

GSK cutting employees at its R & D unit in Collegeville
Months after new research and development head Hal Barron announced a new strategy for his unit, pharmaceutical giant GlaxoSmithKline has laid off employees in its two main R&D hubs — Collegeville, Pa., and Stevenage in the U.K. In 2018, Barron announced a new approach to R&D, prioritizing innovation and moving towards delivering a pipeline of medicines with a focus on immunology, genetically validated targets, and finding platforms and technologies that amplify its science. “As the business… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Jeff Blumenthal Source Type: news

MedImmune spinoff scores breakthrough status for rare autoimmune disease treatment
Viela Bio Inc. has earned a breakthrough therapy designation from the Food and Drug Administration for a product to treat neuromyelitis optica spectrum disorder, a life-threatening autoimmune disease that impacts the central nervous system. The FDA granted breakthrough status to the company’s candidate, inebilizumab, following positive results from a pivotal study that was “the largest monotherapy study ever conducted in NMOSD,” said Dr. Jorn Drappa, chief medical officer and head of research… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Sara Gilgore Source Type: news

At-home genetic kits don't reveal all breast cancer risks
Millions of people have bought into the mail-in DNA testing craze, but a new study indicates consumers should be aware of the limitations of the health tests offered.   Those who expect 23andMe to detect most breast cancer risks are being cautioned after study findings determined almost 90 percent of participants with a BRCA mutation wouldn’t have received a positive from the company’s test, reports The New York Times. The test’s limited scope is to bla me, per The Daily Beast. The study,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Caitlin Mullen Source Type: news

RunLab: finalist
Run Lab is a finalist for the Entrepreneurial Opportunity Contest in partnership with BBVA Compass. For more information on the contest, click here. Company description: RunLab is a movement analysis and gait diagnostics company headquartered in Austin, Texas. Identifying a huge gap in the market for quality, consistency and ease of access to full-body gait evaluation and footwear prescription, RunLab was launched in 2014. Initially speciali zing in gait diagnostics and follow-up care for runners,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Source Type: news

Sempulse: finalist
Sempulse is a finalist for the Entrepreneurial Opportunity Contest in partnership with BBVA Compass. For more information on the contest, click here. Company description: Our goal is to save lives, whether by saving time during the "golden hour" for triage or extending quality healthcare to remote and rural regions. Sempulse has engineered a non-invasive miniature wireless vital signs monitor that adheres to the back of the ear and acquires all five major vital signs immediately — industry-first… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Source Type: news

Why this firm's matriarch left a National Cancer Institute job to move to Orlando
In the last year, Xymogen grew to more than 400 employees, expanded into a 300,000-square-foot campus and recorded more than $100 million in 2018 revenue. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Anjali Fluker Source Type: news

How the ACA and its uncertain future are shaping Birmingham
Nine years later, the Affordable Care Act has delivered mixed results to the Magic City, its employers and the state insurance market. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Oregon's maturing cannabis industry still coping with oversupply and finance issues (Infographic)
Cannabis businesses are most preoccupied with the state's abundance of marijuana and federal regulation but financing and cash flow issues are also concerns. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 19, 2019 Category: Biotechnology Authors: Brandon Sawyer Source Type: news

How this UCSF-grown startup is shaping hospitals ’ best practices
Hoping to stave off preventable mistakes in hospitals, UCSF doctor Arup Roy-Burman co-founded Elemeno Health along with Electronic Arts veteran Ed Nanale. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Hannah Norman Source Type: news

Imperial Health Plan enters Sacramento market
The health plan is joining the Sacramento market to position it for a larger Northern California expansion. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Felicia Alvarez Source Type: news

Unions begin contract talks with Kaiser Permanente in Oregon, six other states
Representatives of 85,000 health care workers began negotiations with Kaiser Permanente on Thursday, more than six months after their old contract expired. The Coalition of Kaiser Permanente Unions contends Kaiser is becoming “just like any other large, for-profit health care corporation.” Kaiser is sitting on $31.5 billion in reserves, pays its CEO more than $16 million a year and 36 executives more than $1 million a year — numbers that are mo re fitting for a for-profit, the workers contend. At… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Bill advances at Texas Capitol to expand low-THC medical marijuana program
A record 63 marijuana-related bills were filed at the Texas Capitol this session. Only one tied to medical marijuana has made much progress, but it's got wide-ranging and bipartisan support. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Kimberly Reeves Source Type: news

Here's the latest on UCF's $175M Lake Nona teaching hospital
The hospital will be part of a campus featuring research, education and health care all in one spot. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Ryan Lynch Source Type: news

Bham health care company raises $2.7M, names new CEO
A Birmingham-based pediatric urgent care company just raised $2.7 million to fuel its rapid growth. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

A seismic shift: Health care industry braces for new earthquake laws
California could see $34 billion to $142 billion in new health care development to keep up with seismic safety laws that go into effect in 2030. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Felicia Alvarez Source Type: news

Bill advances at Texas Capitol to expand low-THC medical marijuana program
A record 63 marijuana-related bills were filed at the Texas Capitol this session. Only one tied to medical marijuana has made much progress, but it's got wide-ranging and bipartisan support. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Kimberly Reeves Source Type: news

Biotech veteran Michael Gilman joins Arrakis full-time after $75M round
Biogen veteran Michael Gilman, a well-known figure in the Boston-area biotech industry, is joining Waltham biotech Arrakis Therapeutics full-time after the startup raised a further $75 million. Arrakis Therapeutics closed a $75 million Series B round Thursday with financing from new investors GV, Alexandria Venture Investments and Chinese investment firm WuXi AppTec Venture Fund, according to a press release. Following the financing round, Gilman will leave the other startup with which he's been… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Behind the licensing deal for St. Jude's 'bubble boy' disease cure
St. Jude and Mustang Bio's exclusive license agreement for the gene therapy could bring in millions of dollars for the hospital. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Jason Bolton Source Type: news

Talaris relaunches in Boston with $100M for organ transplant drug replacement
The newly retooled company will use the money to develop a stem cell treatment that could permanently replace the immuno-supressing drugs people who have received transplants must take to stop their body from rejecting the organ. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

Baby + Co. closes N.C. operations a year after infant deaths
A year after a state investigation into a Triangle natural-birthing center found "significant concerns," the company has announced the closing of its North Carolina operations. Baby + Company drew scrutiny in 2018 over reports of three infant deaths at its Cary facility in the span of six months – prompting a voluntary review of its operations by the North Carolina Department of Health and Human Services. That report, issued in June 2018, cited 16 areas of concerns, including cleaning and disinfectant… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

Spotlight on wellness at Community Services for Every1
Community Services for Every1 constantly looks for ways to incorporate health and wellness into the lives of employees. “Internally, we have a wellness committee made up of employees from all across our agency,” benefits manager Jennifer Thiebolt said. “Recently we made the decision to incorporate healthy snack options into our vending machine. We also developed the Healthy Spotter program, which is peer-to-pee r recognition for healthy choices. Individuals who are spotted making a healthy choice… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Jane Schmitt Source Type: news

Excelsior partnership helps grow Mount St. Mary's ortho line
The relationship between the two companies grew last year after Excelsior opened a new full-service facility in Niagara Falls. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Tracey Drury Source Type: news

AngioDynamics will sell Namic business for $167.5 million
The sale is expected to close by the end of May. Once that occurs, 330 to 350 AngioDynamics employees are expected to join Medline Industries Inc., a privately-held company headquartered near Chicago. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Robin K. Cooper Source Type: news

Brown gambles on tobacco tax to fund Medicaid, but prospects look iffy
However, even if the proposed tax hike and a tax on employers don't pass, lawmakers say the Medicaid budget won't be cut. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

United Therapeutics sued by generic drug competitors
United Therapeutics Corp. has been sued for “unlawfully impeding competition” by Sandoz Inc. and RareGen LLC, the companies selling a generic form of a drug the Silver Spring biotech had under patent until last month. The lawsuit, filed April 16 in U.S. District Court for the District of New Jersey, alleges that United Therapeutics (NASD AQ: UTHR) placed restrictions on cartridges made by medical device manufacturer Smiths Medical ASD Inc. that are required to administer subcutaneous injections… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 18, 2019 Category: Biotechnology Authors: Sara Gilgore Source Type: news